Glucose Metabolism Disorders  >>  BIAsp 30 (biphasic insulin aspart 30/70 biosimilar)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

17 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
NCT01467323: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Completed
3
303
Europe
biphasic insulin aspart, biphasic human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
09/98
09/98
NCT01486381: Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

Completed
3
22
RoW
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
05/03
05/03
NCT00617565: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Completed
3
219
RoW
biphasic insulin aspart, BIASP, biphasic human insulin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
11/03
11/03
INITIATE, NCT00598793: Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Completed
3
242
US
biphasic insulin aspart, insulin glargine, metformin, pioglitazone
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/04
03/04
NCT00280046: Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

Completed
3
307
RoW
biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
07/04
07/04
NCT01527539: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Completed
3
25
Canada
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
10/04
10/04
NCT01467375: Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Completed
3
89
Canada, RoW
biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
10/04
10/04
PreFER, NCT00605020: Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes

Completed
3
719
Europe
insulin detemir, Levemir, insulin aspart, biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/05
03/05
NCT00184574: Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Completed
3
603
Europe, RoW
biphasic insulin aspart, metformin
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/06
03/06
NCT00318786: Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes

Completed
3
289
Japan
biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
06/07
06/07
NCT00627445: Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Completed
3
441
RoW
biphasic insulin aspart 30, metformin, biphasic insulin aspart 50
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
01/09
01/09
NCT00184600 / 2004-000514-38: Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

Completed
3
708
Europe
biphasic insulin aspart, insulin detemir, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
08/09
08/09
BOOSTâ„¢, NCT01009580 / 2008-005768-15: Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark Data
More
Completed
3
447
Europe, RoW
insulin degludec/insulin aspart, biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
08/10
08/10
BOOSTâ„¢, NCT01059812: A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Completed
3
424
Japan, RoW
insulin degludec/insulin aspart, biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
12/10
12/10
NCT00151697: LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

Completed
3
150
Europe
Novomix 30, Novorapid and Amaryl, Lantus
Rijnstate Hospital
Diabetes Mellitus Type II
 
 
NCT01513590 / 2011-001712-61: A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Completed
3
394
Europe, RoW
insulin degludec/insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
11/12
11/12
BOOST, NCT02762578: Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

Completed
3
543
RoW
insulin degludec/insulin aspart, biphasic insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
05/17
06/17

Download Options